Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma

Constitutive activation of the chemokine receptor CXCR4 has been associated with tumor progression, invasion, and chemotherapy resistance in different cancer subtypes. Although the CXCR4 pathway has recently been suggested as an adverse prognostic marker in diffuse large B-cell lymphoma, its biologi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Haematologica
Main Authors: Recasens-Zorzo, Clara, Cardesa-Salzmann, Teresa, Petazzi, Paolo, Ros-Blanco, Laia, Esteve-Arenys, Anna, Clot, Guillem, Guerrero-Hernández, Martina, Rodríguez, Vanina, Soldini, Davide, Valera, Alexandra, Moros, Alexandra, Climent, Fina, González-Barca, Eva, Mercadal, Santiago, Arenillas, Leonor, Calvo, Xavier, Mate, José Luís, Gutiérrez-García, Gonzalo, Casanova, Isolda, Mangues, Ramón, Sanjuan-Pla, Alejandra, Bueno, Clara, Menéndez, Pablo, Martínez, Antonio, Colomer, Dolors, Tejedor, Roger Estrada, Teixidó, Jordi, Campo, Elias, López-Guillermo, Armando, Borrell, José Ignacio, Colomo, Luis, Pérez-Galán, Patricia, Roué, Gaël
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6442946/
https://ncbi.nlm.nih.gov/pubmed/29954928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2017.180505
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados